Kidney transplant tolerance study
Part of Immune system & allergy, Kidney & urinary clinical trials.
This trial is testing a way to help your body accept a kidney transplant without needing lifelong anti-rejection drugs. It is for people getting a kidney from a living donor who is a relative and has a compatible blood type.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are getting your first or second kidney transplant
- Your donor is a living relative with a compatible blood type
- Your body mass index (BMI) is under 35
- You weigh more than 110 pounds (50 kg)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving you back specially grown immune cells (called Tregs) made from your own blood can help your body accept a new kidney from a living donor with less rejection. It is for people who are ready for a first kidney transplant.
This trial tests a combination of low-dose radiation, chemotherapy, and donor immune cells to help your body accept a living donor kidney without long-term anti-rejection drugs.
This study tests whether receiving a thymus and kidney from the same baby donor can help your body accept the new kidney without needing strong anti-rejection drugs. It is for people who need a kidney transplant and are willing to also receive a thymus from the same donor.
This study looks at how the body’s immune system responds when a kidney transplant shows signs of rejection, using a planned kidney biopsy. It may help doctors better understand what drives rejection and how to improve care in the future.
This Phase 1/2 trial tests how safe AT 1501 is and how it works in people getting their first kidney transplant. It aims to improve transplant outcomes by targeting the immune system, while carefully watching for side effects and immune compatibility issues.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
Hear when a new Kidney Transplant Tolerance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.